In this large population-based study, cancer patients were at higher risk of SARS-CoV-2 infection and had worse outcomes than patients without cancer, and the risk was higher in patients with hematologic cancers and in those with aggressive disease. It was highest among cancer patients undergoing treatment. Triple vaccination was associated with a reduced risk of poor outcome.
author: Matthew C. Cheung, MD, SM of the University of Toronto is the corresponding author.
To access embargo research: Follow this link to our media website. https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.6815)
Editor’s note: See article for additional information including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
Embed this link to give readers free access to the full article This link will be published during embargo hours https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6815?guestAccessKey=24522c3a-b9d4-4e26-bf45-d58917926399&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=22term_content=22
Disclaimer: AAAS and EurekAlert! EurekAlert! is not responsible for the accuracy of news releases posted. Use of information by contributors or via the EurekAlert system.
